Target
Mitogen-activated protein kinase 1 [8-360]
Ligand
BDBM192321
Substrate
n/a
Meas. Tech.
Enzymatic Assay
pH
7.3±n/a
IC50
2.5±n/a nM
Comments
extracted
Citation
 Blake, JFChen, HChicarelli, MJDemeese, JGarrey, RFGaudino, JGazzard, LKaus, RJKintz, SMohr, PJMoreno, DASchwarz, JSiedem, CSWallace, EM Substituted quinazolines as serine/threonine kinase inhibitors US Patent  US9187462 Publication Date 11/17/2015 
Target
Name:
Mitogen-activated protein kinase 1 [8-360]
Synonyms:
ERK2 | Human ERK-2 | MAPK1 | MK01_HUMAN | Mitogen Activated Kinase 1 | Mitogen-activated protein kinase 1 (ERK-2) | Mitogen-activated protein kinase 1 (aa 8-360) | PRKM1 | PRKM2
Type:
n/a
Mol. Mass.:
40835.09
Organism:
Homo sapiens (Human)
Description:
P28482 aa 8-360
Residue:
353
Sequence:
GAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS
  
Inhibitor
Name:
BDBM192321
Synonyms:
US9187462, I-1
Type:
Small organic molecule
Emp. Form.:
C23H22ClFN6O2
Mol. Mass.:
468.911
SMILES:
CC(CO)Nc1ncc2ccc(cc2n1)C(=O)NC(c1cnn(C)c1)c1ccc(Cl)c(F)c1
Structure:
Search PDB for entries with ligand similarity: